Search Results - Kevin Talbot

Refine Results
  1. 1

    Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease by Mireia Herrando-Grabulosa, Caty Casas, Kevin Talbot, José Aguilera

    Published in Toxins (2020-10-01)
    Get full text
    Article


  2. 2

    A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3 by Zhefan Stephen Chen, Xiaoying Huang, Kevin Talbot, Ho Yin Edwin Chan

    Published in Cell Death and Disease (2021-02-01)
    Get full text
    Article


  3. 3

    Personalised penetrance estimation for C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia by Kevin Talbot, Martin R Turner, Alexander G Thompson, Andrew G L Douglas

    Published in BMJ Neurology Open (2024-09-01)
    Get full text
    Article


  4. 4

    An ALS-associated mutation dysregulates microglia-derived extracellular microRNAs in a sex-specific manner by Eleni Christoforidou, Libby Moody, Greig Joilin, Fabio A. Simoes, David Gordon, Kevin Talbot, Majid Hafezparast

    Published in Disease Models & Mechanisms (2024-05-01)
    Get full text
    Article


  5. 5

    The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis by Alexander Bampton, Caroline McHutchison, Kevin Talbot, Michael Benatar, Alexander G. Thompson, Martin R. Turner

    Published in Brain and Behavior (2024-11-01)
    Get full text
    Article


  6. 6

    Modeling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis by Sneha Pandya, Pedro D. Maia, Benjamin Freeze, Ricarda A. L. Menke, Kevin Talbot, Martin R. Turner, Ashish Raj

    Published in NeuroImage (2022-05-01)
    Get full text
    Article


  7. 7

    Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/β-catenin pathway in C9ALS/FTD by Zhefan Stephen Chen, Mingxi Ou, Stephanie Taylor, Ruxandra Dafinca, Shaohong Isaac Peng, Kevin Talbot, Ho Yin Edwin Chan

    Published in Nature Communications (2023-12-01)
    Get full text
    Article


  8. 8

    A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral Sclerosis by David G. Lester, Kevin Talbot, Martin R. Turner, Alexander G. Thompson, the Pooled Resource Open‐Access ALS Clinical Trials Consortium

    Get full text
    Article


  9. 9

    An eye-tracking version of the trail-making test. by Stephen L Hicks, Rakesh Sharma, Amad N Khan, Claire M Berna, Andrea Waldecker, Kevin Talbot, Chris Kennard, Martin R Turner

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  10. 10

    Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients by Greig Joilin, Elizabeth Gray, Alexander G. Thompson, Kevin Talbot, P. Nigel Leigh, Sarah F. Newbury, Martin R. Turner, Majid Hafezparast

    Published in Annals of Medicine (2022-12-01)
    Get full text
    Article


  11. 11

    Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes by James N. Sleigh, Andrew P. Tosolini, David Gordon, Anny Devoy, Pietro Fratta, Elizabeth M.C. Fisher, Kevin Talbot, Giampietro Schiavo

    Published in Cell Reports (2020-03-01)
    Get full text
    Article


  12. 12

    Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS by Alexander G. Thompson, Elizabeth Gray, Philip D. Charles, Michele T. M. Hu, Kevin Talbot, Roman Fischer, Benedikt M. Kessler, Martin R. Turner

    Published in Frontiers in Neuroscience (2021-03-01)
    Get full text
    Article


  13. 13

    The Motor Neuron Disease Register for England, Wales, and Northern Ireland: Protocol for a Population Register by Andrea Biondi, Elizabeth Gray, Modupe Aggreh, Edward Jones, Amber Collingwood, Liam Knox, Andrea Bredin, David Setters, Kevin Talbot, Ammar Al-Chalabi

    Published in JMIR Research Protocols (2026-06-01)
    Get full text
    Article


  14. 14

    Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential by Elizabeth R. Dellar, Lara Nikel, Stephanie Fowler, Björn F. Vahsen, Ruxandra Dafinca, Emily Feneberg, Kevin Talbot, Martin R. Turner, Alexander G. Thompson

    Published in Molecular Neurodegeneration (2025-06-01)
    Get full text
    Article


  15. 15

    TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord by Emily Feneberg, Alexander G. Thompson, Philip D. Charles, Iolanda Vendrell, Benedikt M. Kessler, Roman Fischer, Olaf Ansorge, Elizabeth Gray, Kevin Talbot, Martin R. Turner

    Published in Acta Neuropathologica Communications (2025-08-01)
    Get full text
    Article


  16. 16

    Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. by Dirk Bäumer, Sheena Lee, George Nicholson, Joanna L Davies, Nicholas J Parkinson, Lyndsay M Murray, Thomas H Gillingwater, Olaf Ansorge, Kay E Davies, Kevin Talbot

    Published in PLoS Genetics (2009-12-01)
    Get full text
    Article


  17. 17

    Interaction of Axonal Chondrolectin with Collagen XIXa1 Is Necessary for Precise Neuromuscular Junction Formation by Ana-Maria Oprişoreanu, Hannah L. Smith, Sukrat Arya, Richard Webster, Zhen Zhong, Charlotte Eaton-Hart, Daniel Wehner, Marcos J. Cardozo, Thomas Becker, Kevin Talbot, Catherina G. Becker

    Published in Cell Reports (2020-08-01)
    Get full text
    Article


  18. 18

    Quantitative patterns of motor cortex proteinopathy across ALS genotypes by Matthew Nolan, Connor Scott, Menuka Pallebage Gamarallage, Daniel Lunn, Kilda Carpenter, Elizabeth McDonough, Dan Meyer, Sireesha Kaanumalle, Alberto Santamaria-Pang, Martin R. Turner, Kevin Talbot, Olaf Ansorge

    Published in Acta Neuropathologica Communications (2020-07-01)
    Get full text
    Article


  19. 19

    Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy by Audrey M. Winkelsas, Christopher Grunseich, George G. Harmison, Katarzyna Chwalenia, Carlo Rinaldi, Suzan M. Hammond, Kory Johnson, Melissa Bowerman, Sukrat Arya, Kevin Talbot, Matthew J. Wood, Kenneth H. Fischbeck

    Published in Molecular Therapy: Nucleic Acids (2021-03-01)
    Get full text
    Article


  20. 20

    PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice by Anna J Kordala, Jessica Stoodley, Nina Ahlskog, Muhammad Hanifi, Antonio Garcia Guerra, Amarjit Bhomra, Wooi Fang Lim, Lyndsay M Murray, Kevin Talbot, Suzan M Hammond, Matthew JA Wood, Carlo Rinaldi

    Published in EMBO Molecular Medicine (2023-09-01)
    Get full text
    Article


Search Tools: